Cargando…
Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling
BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is among the malignancies with the highest mortality. The key regulators and their interactive network in HCC pathogenesis remain unclear. Along with genetic mutations, aberrant epigenetic paradigms, including deregulated microRNAs (miRNAs), exer...
Autores principales: | Zhao, Junlong, Li, Huichen, Zhao, Shoujie, Wang, Enxin, Zhu, Jun, Feng, Dayun, Zhu, Yejing, Dou, Weijia, Fan, Qingling, Hu, Jie, Jia, Lintao, Liu, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927270/ https://www.ncbi.nlm.nih.gov/pubmed/33658044 http://dx.doi.org/10.1186/s12943-021-01343-5 |
Ejemplares similares
-
Efficacy evaluation of the combination therapy of sorafenib and transarterial chemoembolization for unresectable HCC: a systematic review and meta-analysis of comparative studies
por: Li, Huichen, et al.
Publicado: (2020) -
The miR-144/451 locus is required for erythroid homeostasis
por: Rasmussen, Kasper D., et al.
Publicado: (2010) -
Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study
por: Bai, Tingting, et al.
Publicado: (2023) -
Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study
por: Zhu, Yejing, et al.
Publicado: (2023) -
Identifying optimal candidates of transarterial chemoembolization (TACE) vs. sorafenib in patients with unresectable hepatocellular carcinoma
por: Zhao, Shoujie, et al.
Publicado: (2020)